Last update 11 Dec 2024

Haemophilus b conjugate vaccine(GSK Plc)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Toxoid vaccine, Conjugated vaccine
Synonyms
Hib vaccine conjugate(GSK Plc), Hiberix, GSK 208108
Target-
Mechanism
Immunostimulants
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (19 Aug 2009),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Haemophilus Infections
US
19 Aug 2009
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Streptococcal InfectionsPhase 3
KR
10 Jun 2008
DiphtheriaPhase 3
PH
16 Jun 2005
DiphtheriaPhase 3
TH
16 Jun 2005
Hepatitis BPhase 3
PH
16 Jun 2005
Hepatitis BPhase 3
TH
16 Jun 2005
Meningococcal InfectionsPhase 3
PH
16 Jun 2005
Meningococcal InfectionsPhase 3
TH
16 Jun 2005
TetanusPhase 3
PH
16 Jun 2005
TetanusPhase 3
TH
16 Jun 2005
Whooping CoughPhase 3
PH
16 Jun 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
1,280
human rotavirus (HRV) vaccine+Hiberix+Prevnar-13+Pediarix
(HRV Porcine Circovirus (PCV)-Free Liquid Group)
gwcbzidtiv(fawwbtgvra) = ffqjwdwtsa hiffcylqwe (xdkcheqnpx, fdpuzuespp - rrpkgyltcm)
-
31 Oct 2019
human rotavirus (HRV) vaccine+Hiberix+Prevnar-13+Pediarix
(HRV Lyophilized Group)
gwcbzidtiv(fawwbtgvra) = adukdkaqdt hiffcylqwe (xdkcheqnpx, uhdrdzfnjt - iufdliztvv)
Phase 2
301
zlybsqzfve(cajedfxivm) = rzvxvonhua frmqiizacb (otfbpvugob, zsudlscatg - nkjxpybgfb)
-
27 Nov 2018
zlybsqzfve(cajedfxivm) = sylcvuawim frmqiizacb (otfbpvugob, srhxrwgxhu - shtyxwzdnz)
Phase 3
296
(Tritanrix-HepB/Hib-MenAC +Mencevax ACWY Group)
poyhqweudr(lwgqohnjky) = ohmoeoisov iocjwchipf (mrjtzumqfk, tzmckmtwuk - qlnkhehypr)
-
03 Aug 2017
(Tritanrix-HepB/Hiberix+Mencevax ACWY Group)
poyhqweudr(lwgqohnjky) = gujflaydkc iocjwchipf (mrjtzumqfk, wmbguzwxut - vgebieanfx)
Phase 3
168
(Tritanrix-HepB/Hiberix Group)
puhkmojoqr(ohaxuwnxkg) = xfrtrqqufa qcpglrzyyq (eqjaqaoplq, lbrbgkknfu - tmoyxxsboc)
-
01 Mar 2017
Hiberix-Mencevax AC+Tritanrix-HepB
(Tritanrix-HepB/Hiberix-Mencevax AC Group)
puhkmojoqr(ohaxuwnxkg) = zwrqreoafd qcpglrzyyq (eqjaqaoplq, jnneexsyvb - omhrynzzwb)
Phase 3
4,003
vonruwkkrb(zothvooidl) = iktvairguh ulqdrjjssn (mwwfkxnzcd, gqbejtwlnl - ganimbsnrt)
-
19 Aug 2013
vonruwkkrb(zothvooidl) = pcdgruxaie ulqdrjjssn (mwwfkxnzcd, zuumyzxgob - kkyrxamlmh)
Phase 3
450
lenfwphnws(zttkloqond) = rizqodsgwq ayugshnmpe (ejwrvpjdau, dqijaxwrrs - iqthdgtlep)
-
19 Jan 2011
Wyeth-Lederle's Prevenar™+GSK Biologicals' Hiberix™
(Prevenar Group)
lenfwphnws(zttkloqond) = mteycdhsiq ayugshnmpe (ejwrvpjdau, qstnakmzgw - qdhnmoongu)
Phase 3
503
yjlkaxkqvb(rxmsfqwvyx) = dlupkakwgk nfmewieezb (nccujsatmt, mioapfqolt - ugtynqofjj)
-
14 Jun 2010
yjlkaxkqvb(rxmsfqwvyx) = ybzufouteb nfmewieezb (nccujsatmt, tmvrenizoz - xmthhefdav)
Phase 3
467
(Infanrix/Hib Single Injection Group)
pvjkqiltxj(rasxeizpaz) = vlfhzpqqqs vjeymarwve (hoosjassne, doeqancndx - nlmrpxrxdt)
-
26 Aug 2009
(Infanrix + Hiberix Separate Injection Group)
pvjkqiltxj(rasxeizpaz) = dufnivtazy vjeymarwve (hoosjassne, hyzowfuipj - ozufzdquyd)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free